Stapokibart's clinical effectiveness in treating moderate-to-severe bullous pemphigoid in the elderly. [PDF]
Front ImmunolDu N, Wang Y, Yang J, Lv X, Min W.
europepmc +1 more source
Case Report: Simultaneous presence of <i>Sarcoptes scabiei</i> and fungal elements in scrapings from a patient with bullous pemphigoid. [PDF]
Front Med (Lausanne)Ye Y, Lv W, Chai L, Li Q, Liu Z, Xia X.
europepmc +1 more source
Tyrosine kinase signaling pathways as therapeutic targets in autoimmune subepidermal blistering skin diseases (pemphigoid diseases). [PDF]
Front ImmunolVikár S, Mócsai A.
europepmc +1 more source
A case series of immune checkpoint inhibitor-induced bullous pemphigoid successfully treated with dupilumab and evidence for the BP180 midportion epitope as a preferential autoantigenic target. [PDF]
Front Med (Lausanne)Didona D +5 more
europepmc +1 more source
Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid. [PDF]
IDCasesVaidyanathan BR, Balaji A.
europepmc +1 more source
Corticosteroid-Sparing Control of Bullous Pemphigoid with Dupilumab and Tripterygium Glycosides: A Real-World Cohort with Longitudinal Transcriptomics. [PDF]
J Inflamm ResWang SH +5 more
europepmc +1 more source
Successful Treatment of Concurrent Bullous Pemphigoid and Psoriasis Vulgaris with Abrocitinib: A Case Report and Literature Review. [PDF]
Clin Cosmet Investig DermatolHu YQ, Zhang JZ, Zhao Y.
europepmc +1 more source
Bullous Systemic Lupus Erythematosus: Clinical Presentation in Two Asian Cases. [PDF]
Case Rep MedNguyen PTT +4 more
europepmc +1 more source
A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis. [PDF]
JID InnovLawson K +8 more
europepmc +1 more source